The manufacturer of Chondroitin sulfate introduced that CS widely exists in human and animal cartilage tissue. Its medicinal preparations mainly contain two isomers of Chondroitin sulfate A and Chondroitin sulfate C. The content of Chondroitin sulfate in the cartilage of animals of different varieties and ages is different. Its pharmacological effects are manifested as:
1. CS can clear the lipids and lipoproteins in the blood, clear the cholesterol in the blood vessels around the heart, prevent and treat Atherosclerosis, and increase the conversion rate of lipids and fatty acids in cells.
2. CS can effectively prevent and treat coronary heart disease. It has anti Atherosclerosis and anti atherogenic plaque formation effect on experimental Arteriosclerosis model; Increase the coronary branch or collateral circulation of Atherosclerosis, and accelerate the healing, regeneration and repair of myocardial necrosis or degeneration caused by experimental coronary Arteriosclerosis or embolization.
3. It can increase the biosynthesis of Messenger RNA (mRNA) and DNA (DNA) in cells and promote cell metabolism.
4. Low anticoagulant activity. Chondroitin sulfate has mild anticoagulant effect, and each lmg of Chondroitin sulfate A is equivalent to 0.45U heparin anticoagulant activity. This anticoagulant activity does not rely on antithrombin III to function, it can exert anticoagulant activity through the fibrinogen system.
5. Chondroitin sulfate also has anti-inflammatory, accelerating wound healing and anti-tumor effects.
